ACRS vs KMX · rev $3.6M vs P/E 19, rev $25.88B
Aclaris Therapeutics Inc (ACRS) versus CarMax Inc (KMX) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
ACRS currently screens at market cap $615.9M. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Not investment advice. Open the ACRS and KMX stock pages for the full models.
Not investment advice.